Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Knufia petricola strain:MA5790

ABSTRACT: Knufia chersonesos mutant Genome sequencing and assembly

PROVIDER: PRJNA393697 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	NMQP01.dat.gz	Other
	NMQP01.fasta.gz	Fasta.gz
	NMQP01.master.dat	Other
	NMQP01.dat.gz	Other

Items per page:

1 - 4 of 4

Similar Datasets

Knufia obscura

Project description:Knufia obscura Genome sequencing and assembly

| PRJNA927011 | ENA

Knufia petricola strain:MA5789

Project description:Knufia chersonesos Genome sequencing and assembly

| PRJNA393270 | ENA

Knufia petricola strain:A95

Project description:Knufia petricola strain:A95 Genome sequencing and assembly

| PRJNA664321 | ENA

Knufia obscura

Project description:Knufia obscura overview

| PRJNA1108396 | ENA

Knufia petricola

Project description:Knufia petricola overview

| PRJNA394170 | ENA

Secretome analysis of Knufia chersonesos MA5789, wt and MA5790 mutant

Project description:The extremotolerant rock-associated black fungus Knufia chersonesos and its nonmelanized spontaneous mutant were selected for a proteomic-based screening towards polyesterases. A non-labeling shotgun analysis of the secretome was performed to compare control and treatment condition (PBAT added to the cultivation media) as well as Wt and Mut.

2020-06-24 | PXD014026 | Pride

Proteome and secretome profiling of Knufia chersonesos MA5789 wt and MA5790 mutant exposed to low sheer simulated microgravity (LSSMG)

Project description:Proteome and secretome of the extremotolerant rock black fungus Knufia chersonesos and its nonmelanized spontaneous mutant were analyzed following the fungus growth under LSSMG in rotating bioreactors (High Aspect Ratio Vessels; HARV). Tandem Mass Tags (TMS)-based quantitative shotgun proteomics was applied to compare gravity to microgravity conditions as well as to elucidate differences in the response between wild type and mutant strain.

2021-05-31 | PXD022898 | Pride

Knufia epidermidis from spanish clinical isolation

Project description:A clinical case report of Knufia epidermidis a rare fungus causing phaeohyphomycosis

| PRJEB27921 | ENA

Proteomic analysis of the dpp3 knockout mutant, the reconstituted strain and the wild-type strain of Candida lusitaniae

Project description:Candida lusitaniae is an emerging human opportunistic yeast, which can switch from yeast to pseudohyphae, and one of the rare Candida species capable of sexual reproduction. Its haploid genome and the genetic tools available make it a model of interest to study gene function. This study describes the consequences of DPP3 inactivation on cell morphology and mating, both altered in the dpp3Δ knock-out. Interestingly, reintroducing a wild-type copy of the DPP3 gene in the dpp3Δ mutant failed to restore the wild-type phenotypes. Proteomic analyses showed that about 150 proteins were statistically deregulated in the dpp3Δ mutant, and that most of them did not return to their wild-type level in the reconstituted DPP3 strain. The analysis of the segregation of the dpp3Δ mutation and the phenotypes in the progeny of a cross (between the dpp3Δ knock-out and a wild-type strain) showed that the phenotypes are not linked to dpp3Δ, but to a secondary mutation. Genome sequencing of the dpp3Δ mutant allowed us to identify this secondary mutation.

2023-05-02 | PXD020220 | Pride

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data